We are live on
!
Find out more
LRPA
L. Roy Papp & Associates Portfolio holdings
AUM
$951M
1-Year Est. Return
29.05%
This Fund
S&P 500
This Quarter
Est. Return
+8.28%
1 Year Est. Return
+29.05%
3 Year Est. Return
+64.27%
5 Year Est. Return
+82.71%
10 Year Est. Return
+368.72%
AUM
$792M
AUM Growth
+$95.2M
(+14%)
Cap. Flow
+$40.7M
Cap. Flow
% of AUM
5.14%
Top 10 Holdings %
Top 10 Hldgs %
37.69%
Holding
178
New
11
Increased
73
Reduced
35
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$4.91M |
| 2 |
Microsoft
MSFT
|
+$3.27M |
| 3 |
Visa
V
|
+$2.67M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.52M |
| 5 |
Accenture
ACN
|
+$2.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$1.4M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$699K |
| 3 |
LHDX
Lucira Health, Inc. Common Stock
LHDX
|
+$549K |
| 4 |
Weyerhaeuser
WY
|
+$473K |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$452K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.02% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.27% |
| 4 | Industrials | 11.93% |
| 5 | Communication Services | 7.18% |
Similar funds
LEA
IC
WAM
CFO
GL
PO
IGGA
DG
L. Roy Papp & Associates's Q2 2021 Portfolio in Review
As of Q2 2021, L. Roy Papp & Associates held 178 positions worth $792M, up 14% from $697M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
L. Roy Papp & Associates deployed $40.7M of net new capital in Q2 2021, opening 11 new positions and adding to 73 existing holdings. Its largest new stake was Zoom: 14,751 shares worth $5.71M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was PRA Health Sciences, Inc., an estimated $699K trimmed.
- L. Roy Papp & Associates's largest Q2 2021 buy was Zoom: 14,751 shares worth $5.71M.
- L. Roy Papp & Associates added most to Microsoft in Q2 2021, an estimated $3.27M increase.
- L. Roy Papp & Associates's biggest Q2 2021 reduction was PRA Health Sciences, Inc., cutting an estimated $699K.
- L. Roy Papp & Associates fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.4M.
- L. Roy Papp & Associates's ten largest holdings make up 38% of its $792M portfolio in Q2 2021.
- L. Roy Papp & Associates opened 11 new positions and closed 6 in Q2 2021.
- L. Roy Papp & Associates's portfolio value rose 14% quarter-over-quarter to $792M.
Based on L. Roy Papp & Associates's 13F filing for Q2 2021, filed 9 Aug 2021.